Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Dicerna Pharmaceutic (DRNA)

19.56   -0.95 (-4.63%) 06-04 16:00
Open: 20.21 Pre. Close: 20.51
High: 20.7 Low: 19.11
Volume: 831,705 Market Cap: 1,446M
Dicerna Pharmaceuticals Inc is a biopharmaceutical company. It develops ribonucleic acid interference-based pharmaceuticals for treating diseases involving liver, including rare, chronic liver, cardiovascular and viral infections.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 20.725 - 20.854 20.854 - 20.946
Low: 18.819 - 18.972 18.972 - 19.08
Close: 19.356 - 19.583 19.583 - 19.744

Technical analysis

as of: 2020-06-04 4:30:29 PM
Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 26.40     One year: 29.16
Support: Support1: 18.77    Support2: 15.62
Resistance: Resistance1: 22.60    Resistance2: 24.97
Pivot: 21.51
Moving Average: MA(5): 20.74     MA(20): 21.84
MA(100): 19.96     MA(250): 18.32
MACD: MACD(12,26): -0.14     Signal(9): 0.21
Stochastic oscillator: %K(14,3): 14.31     %D(3): 17.53
RSI: RSI(14): 43.23
52-week: High: 27.68  Low: 11.75  Change(%): 51.4
Average Vol(K): 3-Month: 67266  10-Days: 61069

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
DRNA has closed above bottom band by 1.7%. Bollinger Bands are 10.6% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Sun, 10 May 2020
Were Hedge Funds Right About Dicerna Pharmaceuticals Inc (DRNA)? - Yahoo Finance

Sat, 09 May 2020
Dicerna Pharmaceuticals Inc (DRNA) Q1 2020 Earnings Call Transcript - Motley Fool

Thu, 07 May 2020
Dicerna Pharmaceuticals (DRNA) Reports Q1 Loss, Misses Revenue Estimates - Yahoo Finance

Mon, 11 May 2020
Dicerna Pharmaceuticals, Inc. (DRNA) CEO Douglas Fambrough on Q1 2020 Results - Earnings Call Transcript - Seeking Alpha

Mon, 18 May 2020
Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) Analysts Are Way More Bearish Than They Used To Be - Yahoo Finance

Thu, 07 May 2020
Dicerna Pharmaceuticals: 1Q Earnings Snapshot - San Francisco Chronicle

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 74
Shares Float (M) 57
% Held by Insiders 7.49
% Held by Institutions 83.07
Shares Short (K) 3,040
Shares Short P. Month (K) 3,690

Stock Financials

EPS -1.680
EPS Est This Year -2.700
EPS Est Next Year -2.760
Book Value (p.s.) 2.410
Profit Margin -213.04
Operating Margin -228.33
Return on Assets (ttm) -13.5
Return on Equity (ttm) -65.3
Qtrly Rev. Growth 995.2
Gross Profit (p.s.) -1.156
Sales Per Share 0.742
EBITDA (p.s.) -1.672
Qtrly Earnings Growth
Operating Cash Flow (M) 248
Levered Free Cash Flow (M) 95

Stock Valuations

PE Ratio -11.64
PEG Ratio
Price to Book value 8.12
Price to Sales 26.37
Price to Cash Flow 5.83

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.